Trials (North Estonia Medical Centre): Revision history

6 December 2025

• curprev 12:4212:42, 6 December 2025‎ Lucas talk contribs‎ m 67,196 bytes +1,701‎ Update categories. undo

2 December 2025

• curprev 16:3216:32, 2 December 2025‎ Francine talk contribs‎ 65,495 bytes +7‎ No edit summary undo
• curprev 14:0014:00, 2 December 2025‎ Lucas talk contribs‎ m 65,488 bytes +10,687‎ Update categories. undo

5 November 2024

• curprev 23:3823:38, 5 November 2024‎ Victor talk contribs‎ 54,801 bytes +12‎ No edit summary undo

4 January 2024

• curprev 14:3514:35, 4 January 2024‎ Francine talk contribs‎ 54,789 bytes 0‎ No edit summary undo
• curprev 14:3314:33, 4 January 2024‎ Francine talk contribs‎ 54,789 bytes +1‎ No edit summary undo Tag: Manual revert
• curprev 14:3314:33, 4 January 2024‎ Francine talk contribs‎ 54,788 bytes −1‎ No edit summary undo
• curprev 14:3214:32, 4 January 2024‎ Francine talk contribs‎ 54,789 bytes +1,083‎ No edit summary undo

1 December 2023

• curprev 20:4520:45, 1 December 2023‎ Francine talk contribs‎ 53,706 bytes +53,706‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to North Estonia Medical Centre '''NCTID''': NCT02205047 '''Title''': Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma '''Study Summary''': The purpose of this study is to find out whether either trastuzumab or the combination of trastuzumab and pertuzumab with standard chemotherapy shows more activity against gastro-oesophageal aden..."